RCM
KYTH

RA Capital Management’s KYTHERA BIOPHARMACEUTICALS, INC COM KYTH Stock Holding History

RA Capital Management’s Portfolio KYTH Stock Details KYTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-22,750
Closed -$789K – 62
2014
Q4 		$789K Hold
22,750
– – 0.08% 50
2014
Q3 		$745K Buy
+22,750
New +$801K 0.09% 43

Other funds holding KYTH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

RA Capital Management's KYTH Position: Q1 2015 in Review

RA Capital Management sold out of KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) in Q1 2015, closing a stake of 22,750 shares — an estimated $789K sold.

RA Capital Management first reported a position in KYTH in Q3 2014 and held it in 2 quarters. The position peaked at $789K in Q4 2014. 126 funds tracked by Wall St. Rank hold KYTH as of Q1 2015.

  • RA Capital Management reported no remaining KYTHERA BIOPHARMACEUTICALS, INC COM position as of Q1 2015 after selling out during the quarter.
  • RA Capital Management sold 22,750 KYTHERA BIOPHARMACEUTICALS, INC COM shares in Q1 2015, an estimated $789K.
  • RA Capital Management first reported a position in KYTHERA BIOPHARMACEUTICALS, INC COM in Q3 2014 and held it in 2 quarters.
  • RA Capital Management's KYTHERA BIOPHARMACEUTICALS, INC COM position peaked at $789K in Q4 2014.
  • 126 funds tracked by Wall St. Rank held KYTHERA BIOPHARMACEUTICALS, INC COM as of Q1 2015.

Based on RA Capital Management's 13F filing for Q1 2015, filed 15 May 2015.